Literature DB >> 28622027

Communicating with Sensation Seekers: An fMRI Study of Neural Responses to Antidrug Public Service Announcements.

Lewis Donohew1, Michelle DiBartolo2, Xun Zhu2, Chelsie Benca2, Elizabeth Lorch3, Seth M Noar1, Thomas H Kelly4, Jane E Joseph2.   

Abstract

This study examined the neural basis of processing high- and low-message sensation value (MSV) antidrug public service announcements (PSAs) in high (HSS) and low sensation seekers (LSS) using fMRI. HSS more strongly engaged the salience network when processing PSAs (versus LSS), suggesting that high-MSV PSAs attracted their attention. HSS and LSS participants who engaged higher level cognitive processing regions reported that the PSAs were more convincing and believable and recalled the PSAs better immediately after testing. In contrast, HSS and LSS participants who strongly engaged visual attention regions for viewing PSAs reported lower personal relevance. These findings provide neurobiological evidence that high-MSV content is salient to HSS, a primary target group for antidrug messages, and additional cognitive processing is associated with higher perceived message effectiveness.

Entities:  

Mesh:

Year:  2017        PMID: 28622027      PMCID: PMC6190582          DOI: 10.1080/10410236.2017.1331185

Source DB:  PubMed          Journal:  Health Commun        ISSN: 1041-0236


  30 in total

1.  Recognition of emotional prosody and verbal components of spoken language: an fMRI study.

Authors:  T W Buchanan; K Lutz; S Mirzazade; K Specht; N J Shah; K Zilles; L Jäncke
Journal:  Brain Res Cogn Brain Res       Date:  2000-06

2.  Perceived message sensation value (PMSV) and the dimensions and validation of a PMSV scale.

Authors:  Philip Palmgreen; Michael T Stephenson; Maureen W Everett; John R Baseheart; Regina Francies
Journal:  Health Commun       Date:  2002

Review 3.  The anatomy of language: a review of 100 fMRI studies published in 2009.

Authors:  Cathy J Price
Journal:  Ann N Y Acad Sci       Date:  2010-03       Impact factor: 5.691

4.  Individual differences in drug abuse vulnerability: d-amphetamine and sensation-seeking status.

Authors:  Thomas H Kelly; Glenn Robbins; Catherine A Martin; Mark T Fillmore; Scott D Lane; Nancy G Harrington; Craig R Rush
Journal:  Psychopharmacology (Berl)       Date:  2006-09-14       Impact factor: 4.530

5.  Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support.

Authors:  Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde
Journal:  J Biomed Inform       Date:  2008-09-30       Impact factor: 6.317

6.  Brain activations during pain: a neuroimaging meta-analysis of patients with pain and healthy controls.

Authors:  Karin B Jensen; Christina Regenbogen; Margarete C Ohse; Johannes Frasnelli; Jessica Freiherr; Johan N Lundström
Journal:  Pain       Date:  2016-06       Impact factor: 6.961

7.  Neural activity during health messaging predicts reductions in smoking above and beyond self-report.

Authors:  Emily B Falk; Elliot T Berkman; Danielle Whalen; Matthew D Lieberman
Journal:  Health Psychol       Date:  2011-03       Impact factor: 4.267

8.  Content matters: neuroimaging investigation of brain and behavioral impact of televised anti-tobacco public service announcements.

Authors:  An-Li Wang; Kosha Ruparel; James W Loughead; Andrew A Strasser; Shira J Blady; Kevin G Lynch; Dan Romer; Joseph N Cappella; Caryn Lerman; Daniel D Langleben
Journal:  J Neurosci       Date:  2013-04-24       Impact factor: 6.167

9.  Reduced prefrontal and temporal processing and recall of high "sensation value" ads.

Authors:  Daniel D Langleben; James W Loughead; Kosha Ruparel; Jonathan G Hakun; Samantha Busch-Winokur; Matthew B Holloway; Andrew A Strasser; Joseph N Cappella; Caryn Lerman
Journal:  Neuroimage       Date:  2009-01-14       Impact factor: 6.556

Review 10.  The neural basis of mentalizing.

Authors:  Chris D Frith; Uta Frith
Journal:  Neuron       Date:  2006-05-18       Impact factor: 17.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.